[1]
A. D’Alonzo and C. Bighin, “HER2-positive breast cancer with brain metastasis: long-lasting response after lapatinib treatment: Carcinoma mammario HER2-positivo con metastasi cerebrali: risposta prolungata dopo trattamento con lapatinib”, AboutOpen, vol. 4, no. 1, pp. 32–34, Jun. 2018.